Pharming (PHAR) Shares Outstanding (2018 - 2026)

Pharming (PHAR) has 8 years of Shares Outstanding (Entity) data on file, last reported at $701.7 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 3.14% year-over-year to $701.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $701.7 million (up 3.14% YoY) and the FY2025 annual result came in at $701.7 million, up 3.14% from the prior year.
• Shares Outstanding (Entity) climbed to $701.7 million in Q4 2025, from $680.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $701.7 million in Q4 2025 to a low of $648.7 million in Q4 2021.
• A 5-year average of $671.6 million and a median of $671.1 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) climbed 1.17% — and 2025, when it climbed 3.14%.
• Tracing PHAR's Shares Outstanding (Entity) over 5 years: stood at $648.7 million in 2021, then grew by 1.17% to $656.3 million in 2022, then rose by 2.24% to $671.1 million in 2023, then climbed by 1.38% to $680.3 million in 2024, then grew by 3.14% to $701.7 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $701.7 million (Q4 2025), $680.3 million (Q4 2024), and $671.1 million (Q4 2023), per Business Quant data.